Theodrenaline
Chemical compound used as a cardiac stimulant
- C01CA23 (WHO)
- (RS)-7-(2-{[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino}ethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
- 13460-98-5
- 71857
- 64874
N
- RW8PD99T8G
- D07155
Y
- Interactive image
- Cn1c2c(c(=O)n(c1=O)C)n(cn2)CCNCC(c3ccc(c(c3)O)O)O
InChI
- InChI=1S/C17H21N5O5/c1-20-15-14(16(26)21(2)17(20)27)22(9-19-15)6-5-18-8-13(25)10-3-4-11(23)12(24)7-10/h3-4,7,9,13,18,23-25H,5-6,8H2,1-2H3N
- Key:WMCMJIGLYZDKRN-UHFFFAOYSA-NN
N
Y (what is this?) (verify)Theodrenaline (INN), also known as noradrenalinoethyltheophylline, is a chemical linkage of norepinephrine (noradrenaline) and theophylline used as a cardiac stimulant.[1]
It is sometimes combined with cafedrine.[1]
See also
- Cafedrine
- Fenethylline
References
- ^ a b Usichenko TI, Foellner S, Gruendling M, Feyerherd F, Lehmann C, Wendt M, Pavlovic D (March 2006). "Akrinor-induced relaxation of pig coronary artery in vitro is transformed into alpha1-adrenoreceptor-mediated contraction by pretreatment with propranolol". Journal of Cardiovascular Pharmacology. 47 (3): 450–5. doi:10.1097/01.fjc.0000211710.87863.89. PMID 16633089. S2CID 20221167.
- v
- t
- e
Cardiac stimulants excluding cardiac glycosides (C01C)
dopaminergic agents
| Adrenergic agonists |
| ||||||
|---|---|---|---|---|---|---|---|
| Dopamine agonists | |||||||
| Both | |||||||
| Unknown/ungrouped |
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
 | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
